Hematology-Oncology Therapy

324314-1740/9781260117400

ISBN

9781260117400

作者/出版社

Boyiadzis / McGraw-Hill

出版年代/版次

2022/3

定價NT$ 8,500
NT$ 8,075
數量

重量:5.9kg  頁數:2851  裝訂:精裝 開數:28.2 x 22 cm 印刷:雙色


The essential therapy guide to cancer, hematologic disorders, and supportive care―updated with the latest treatment regimens

Hematology-Oncology Therapy, Third Edition, is an up-to-date, comprehensive therapy guide that delivers more than 800 treatment regimens in a succinct, uniform format.  Supported by the latest practice guidelines, peer-reviewed literature, and insights from experts in the field, this peerless resource integrates extensive information critical to both office- and hospital-based practice of hematology and oncology.

Hematology-Oncology Therapy is divided into four sections:

  • Cancer Regimens: Covers administration, toxicity, dose modification, monitoring, supportive care, and the efficacy of commonly used and recently approved therapeutic regimens, and includes expert opinion and critical information on epidemiology, pathology, work-up, and staging, as well as survival data
  • Antiemetics, Growth Factors, Dose Modification and Drug Preparation: Provides in-depth coverage of antiemetics, growth factors, and the administration and formulation of anti-cancer drugs
  • Supportive Care, Complications, and Screening (online): Offers thorough coverage of topics commonly encountered in clinical hematology-oncology practice
  • Selected Hematologic Diseases (online): provides an authoritative guide to therapy for principal diseases in consultative hematology

The entire content is now online at AccessHemOnc.com. The online platform created for the third edition will be continually updated, including newly approved regimens.